15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 8 firms covering LifeMD Inc, 8 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $10.00 to $10.00, so the covering firms are broadly aligned. The average target of $10.00 sits 158% above the current $3.88. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.17 next quarter toward $0.52 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS8 ratings
Moderate Buy
Strong Buy00%
Buy8100%
Hold00%
Sell00%
Strong Sell00%
Based on 8 analysts giving stock ratings to LifeMD Inc.
As of Jul, 8 of 8 firms rate LFMD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LFMD EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.11 – $0.23 · 2 analysts · -304% YoY
Next period, 2 analysts expect LifeMD Inc to earn $0.17 a share (range $0.11 – $0.23), versus $-0.08 a year earlier. Full-year consensus is $0.14, growing to $0.52 the year after.
REVENUE · NEXT QUARTER
$58.6M
Range $57.0M – $60.8M · 2 analysts · -3% YoY
Revenue is expected to reach $58.6M (range $57.0M – $60.8M), -2.7% year-over-year. Full-year consensus is $222.0M, rising to $260.9M next year.
Top analysts covering LifeMD Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LFMD.
#1
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$10.00+158.1% to target
Overall win rate
34%
+ Follow
#2
Scott Schoenhaus
Keybanc · Rank #345
Buy
No targeton LFMD
Overall win rate
29%
+ Follow
#3
David Larsen
BTIG
Buy
$10.00+158.1% to target
Coverage
—
+ Follow
#4
Steven Valiquette
Mizuho
Buy
$8.00+106.5% to target
Coverage
—
+ Follow
#5
IZ
Ilya Zubkov
Freedom Capital Markets
Buy
$10.00+158.1% to target
Coverage
—
+ Follow
LFMD stock forecast FAQ
What is LFMD's average 12-month price target?+
The 3 analysts with a live target average $10.00 for LifeMD Inc over the next 12 months, ranging from a $10.00 high to a $10.00 low.
Is LFMD stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 8 analyst ratings, 8 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover LFMD?+
8 analysts have an active rating on LifeMD Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering LFMD?+
Among analysts who currently cover LFMD, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #238). Their current call is Buy with a $10.00 target.
What is LifeMD Inc's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.11 – $0.23) across 2 analysts. Full-year EPS is projected at $0.14, rising to $0.52 the following year.
How much revenue is LifeMD Inc expected to report next quarter?+
Consensus revenue is $58.6M (range $57.0M – $60.8M). Full-year revenue is projected at $222.0M, growing to $260.9M next year.
Have analysts been upgrading or downgrading LFMD lately?+
As of Jul, 8 of 8 firms rate LFMD a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LFMD calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
